Gene, Cell and Tissue

Published by: Kowsar

Absence of Immune Response as a Sign of Tissue Tolerance in Small-Cell Lung Cancer

Antonio Manenti 1 , Luca Roncati 2 , * , Pamela Sighinolfi 2 and Giuseppe Barbolini 2
Authors Information
1 Department of Medical and Surgical Sciences, Section of Surgery, University of Modena and Reggio Emilia, Modena, Italy
2 Department of Diagnostic and Clinical Medicine and Public Health, Section of Pathology, University of Modena and Reggio Emilia, Modena, Italy
Article information
  • Gene, Cell and Tissue: July 01, 2014, 1 (2); e20330
  • Published Online: June 24, 2014
  • Article Type: Brief Report
  • Received: May 19, 2014
  • Revised: June 4, 2014
  • Accepted: June 8, 2014
  • DOI: 10.17795/gct-20330

To Cite: Manenti A, Roncati L, Sighinolfi P, Barbolini G. Absence of Immune Response as a Sign of Tissue Tolerance in Small-Cell Lung Cancer, Gene Cell Tissue. 2014 ; 1(2):e20330. doi: 10.17795/gct-20330.

Copyright © 2014, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res. 2008; 14(16): 5220-7[DOI][PubMed]
  • 2. Shigematsu Y, Hanagiri T, Shiota H, Kuroda K, Baba T, Ichiki Y, et al. Immunosuppressive effect of regulatory T lymphocytes in lung cancer, with special reference to their effects on the induction of autologous tumor-specific cytotoxic T lymphocytes. Oncol Lett. 2012; 4(4): 625-30[DOI][PubMed]
  • 3. Karagoz B, Bilgi O, Gumus M, Erikci AA, Sayan O, Turken O, et al. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Med Oncol. 2010; 27(1): 29-33[DOI][PubMed]
  • 4. Hiraoka K, Miyamoto M, Cho Y, Suzuoki M, Oshikiri T, Nakakubo Y, et al. Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer. 2006; 94(2): 275-80[DOI][PubMed]
  • 5. Ruffini E, Asioli S, Filosso PL, Lyberis P, Bruna MC, Macri L, et al. Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms. Ann Thorac Surg. 2009; 87(2): 365-71[DOI][PubMed]
  • 6. Black CC, Turk MJ, Dragnev K, Rigas JR. Adenocarcinoma contains more immune tolerance regulatory t-cell lymphocytes (versus squamous carcinoma) in non-small-cell lung cancer. Lung. 2013; 191(3): 265-70[DOI][PubMed]
  • 7. Roncati L, Manenti A, Sighinolfi P. Immunohistochemical improvement in the analysis of the lymphatic metastases from lung carcinoma. Ann Thorac Surg. 2014; 97(1): 380-1[DOI][PubMed]
  • 8. Dingemans KP, Mooi WJ. Ultrastructure of tumour invasion and desmoplastic response of bronchogenic squamous cell carcinoma. Virchows Arch A Pathol Anat Histopathol. 1987; 411(3): 283-91[PubMed]
  • 9. Filosso PL, Ruffini E, Di Gangi S, Guerrera F, Bora G, Ciccone G, et al. Prognostic factors in neuroendocrine tumours of the lung: a single-centre experience. Eur J Cardiothorac Surg. 2014; 45(3): 521-6[DOI][PubMed]
  • 10. Wang J, Wang B, Zhao W, Guo Y, Chen H, Chu H, et al. Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis. PLoS One. 2012; 7(12)[DOI][PubMed]
  • 11. Strano S, Lupo A, Lococo F, Schussler O, Loi M, Younes M, et al. Prognostic significance of vascular and lymphatic emboli in resected pulmonary adenocarcinoma. Ann Thorac Surg. 2013; 95(4): 1204-10[DOI][PubMed]
  • 12. Schwartz AM, Rezaei MK. Diagnostic surgical pathology in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5 Suppl)-62S[DOI][PubMed]
  • 13. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol. 2003; 200(4): 429-47[DOI][PubMed]
  • 14. Bremnes RM, Donnem T, Al-Saad S, Al-Shibli K, Andersen S, Sirera R, et al. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J Thorac Oncol. 2011; 6(1): 209-17[DOI][PubMed]
  • 15. Wald O, Izhar U, Amir G, Kirshberg S, Shlomai Z, Zamir G, et al. Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: role in non-small cell lung cancer tumor proliferation. J Thorac Cardiovasc Surg. 2011; 141(6): 1503-12[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments